Actavis announces senior appointments

Following Robert Wessman’s departure as CEO, a number of changes in senior management have taken place at the generic pharmaceuticals manufacturer. Actavis Group, the international generic drug company, has announced that it has appointed Gudbjorg Edda Eggertsdottir as Deputy CEO. Valur Ragnarsson will become the new Executive Vice President of Third-Party Sales ... Read More...

Actavis CEO to present at UBS pharmaceuticals conference

Robert Wessman will speak on “The strategy and competitiveness of Actavis in a fiercely competitive environment” in London on Wednesday. Actavis generic pharmaceuticals have announced that its President & CEO, Robert Wessman, will discuss “The strategy and competitiveness of Actavis in a fiercely competitive environment” at the annual UBS Global ... Read More...